Home › Funds › CRCM LP › BNR

CRCM LP position in BNR

BURNING ROCK BIOTECH LTD · Health Care

CRCM LP reported holding 259,814 shares of BNR (BURNING ROCK BIOTECH LTD) in its Q3 2026 13F filing — a position valued at US$4.6M, representing 2.59% of its reported portfolio and ranking #8 among its reported holdings. CRCM LP has disclosed BNR holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)259.81K sh
Reported value held$4.58M
Portfolio Weight2.59%
First reportedQ4 2024
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How CRCM LP's BNR position evolved

CRCM LP first disclosed a stake in BNR in Q4 2024 at 325,969 shares (US$2.2M). The position peaked in Q4 2025 at 491,426 shares, worth US$9.9M. Across 8 filings, CRCM LP increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 259,814 shares valued at US$4.6M — an increase of 47,817 shares quarter over quarter.. Notable position changes include a 31% trim in Q1 2025 (shares fell 30% over the following quarter), a 122% increase in Q4 2025 (shares fell 20% over the following quarter), a 43% trim in Q1 2026 (shares fell 48% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 325.97K $2.20M New
Q1 2025 226.29K $1.02M Reduce
Q2 2025 194.77K $615.46K Reduce
Q3 2025 221.57K $1.92M Add
Q4 2025 491.43K $9.90M Add
Q1 2026 282.10K $4.60M Reduce
Q2 2026 212.00K $1.77M Reduce
Q3 2026 259.81K $4.58M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BNR and 13F data

BNR (BURNING ROCK BIOTECH LTD) is a Health Care company. 19 other funds we track also report a position in BNR — the largest reported positions include Kynam Capital Management, LP (US$10.5M), HSG Holding Ltd (US$178K), SHEN NEIL NANPENG (US$36K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BNR

All BNR fund holders →

FAQ

How long has CRCM LP held BNR?

CRCM LP has disclosed BNR holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is CRCM LP's current position in BNR?

As of Q3 2026, CRCM LP holds 259.81K shares of BNR (BURNING ROCK BIOTECH LTD), valued at $4.58M, representing 2.59% of its reported portfolio and ranking #8.

Has CRCM LP been buying or selling BNR?

In the latest 13F filing (Q3 2026), CRCM LP increased its position in BNR. The position peaked in Q4 2025 at 491.43K shares.

Which other funds hold BNR?

Other major institutional holders of BNR include Kynam Capital Management, LP, HSG Holding Ltd, SHEN NEIL NANPENG, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.